Back to Search Start Over

Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation

Authors :
Joshua K. Wong
Helen S. Mayberg
Doris D. Wang
R. Mark Richardson
Casey H. Halpern
Lothar Krinke
Mattia Arlotti
Lorenzo Rossi
Alberto Priori
Sara Marceglia
Ro’ee Gilron
James F. Cavanagh
Jack W. Judy
Svjetlana Miocinovic
Annaelle D. Devergnas
Roy V. Sillitoe
Stephanie Cernera
Carina R. Oehrn
Aysegul Gunduz
Wayne K. Goodman
Erika A. Petersen
Helen Bronte-Stewart
Robert S. Raike
Mahsa Malekmohammadi
David Greene
Petra Heiden
Huiling Tan
Jens Volkmann
Valerie Voon
Luming Li
Pankaj Sah
Terry Coyne
Peter A. Silburn
Cynthia S. Kubu
Anna Wexler
Jennifer Chandler
Nicole R. Provenza
Sarah R. Heilbronner
Marta San Luciano
Christopher J. Rozell
Michael D. Fox
Coralie de Hemptinne
Jaimie M. Henderson
Sameer A. Sheth
Michael S. Okun
Source :
Frontiers in Human Neuroscience, Vol 16 (2023)
Publication Year :
2023
Publisher :
Frontiers Media S.A., 2023.

Abstract

The deep brain stimulation (DBS) Think Tank X was held on August 17–19, 2022 in Orlando FL. The session organizers and moderators were all women with the theme women in neuromodulation. Dr. Helen Mayberg from Mt. Sinai, NY was the keynote speaker. She discussed milestones and her experiences in developing depression DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging DBS technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank X speakers was that DBS has continued to expand in scope however several indications have reached the “trough of disillusionment.” DBS for depression was considered as “re-emerging” and approaching a slope of enlightenment. DBS for depression will soon re-enter clinical trials. The group estimated that globally more than 244,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia, and Australia; cutting-edge technologies, closed loop DBS, DBS tele-health, neuroethics, lesion therapy, interventional psychiatry, and adaptive DBS.

Details

Language :
English
ISSN :
16625161
Volume :
16
Database :
Directory of Open Access Journals
Journal :
Frontiers in Human Neuroscience
Publication Type :
Academic Journal
Accession number :
edsdoj.6505a13e4d1f44f2a4f4feba26d2428d
Document Type :
article
Full Text :
https://doi.org/10.3389/fnhum.2022.1084782